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Abstract 
In  recent  years,  omic  analyses  have  been
proposed as possible approaches to diagnosis,
in particular for tumours, as they should be
able to provide quantitative tools to detect and
measure  abnormalities  in  gene  and  protein
expression,  through  the  evaluation  of  tran-
scription  and  translation  products  in  the
abnormal  vs normal  tissues.  Unfortunately,
this approach proved to be much less powerful
than expected, due to both intrinsic technical
limits and the nature itself of the pathological
tissues to be investigated, the heterogeneity
deriving from polyclonality and tissue pheno-
type variability between patients being a major
limiting factor in the search for unique omic
biomarkers. Especially in the last few years,
the application of refined techniques for inves-
tigating  gene  expression  in  situ has  greatly
increased  the  diagnostic/prognostic  potential
of histochemistry, while the progress in light
microscopy technology and in the methods for
imaging molecules in vivo have provided valu-
able tools for elucidating the molecular events
and the basic mechanisms leading to a patho-
logical  condition.  Histochemical  techniques
thus  remain  irreplaceable  in  pathologist’s
armamentarium, and it may be expected that
even in the future histochemistry will keep a
leading  position  among  the  methodological
approaches for clinical pathology.
Introduction
Identification  of  reliable  and  unequivocal
diagnostic and prognostic markers is the ulti-
mate goal of pathologists. Following the pio-
neering  intuition  of  Giovanni  Battista
Morgagni (1682-1771), who first attempted to
relate changes in macroscopic anatomy to the
altered  physiological  features  characterizing
diseases,  pathologists  aim  at  detecting  the
most  appropriate  biomarker(s)  enabling
recognition of the earliest signs of a patholog-
ical condition.
In  recent  years,  genomics  and,  especially,
proteomics and transcriptomics did enter the
pathologist’s practice, and were initially fore-
seen as the final approach to diagnosis, in par-
ticular for tumours. In principle, omic analyses
should provide quantitative tools to detect and
measure  abnormalities  in  gene  and  protein
expression,  through  the  evaluation  of  tran-
scription  and  translation  products  in  the
abnormal vs normal tissues.1
Unfortunately,  this  approach  proved  to  be
much less powerful than expected, due to both
intrinsic technical limits and the nature itself
of the pathological tissues to be investigated.
In fact, results from omic analyses reflect the
contents in transcripts or proteins of whole cell
extracts,  whereas  the  occurrence  of  gene
expression  abnormalities  in  a  pathological
specimen may often be restricted to minor tis-
sue fractions: this makes almost impossible to
detect tiny quantitative changes in one or few
aberrantly  expressed  molecules.  The  hetero-
geneity deriving from polyclonality and tissue
phenotype  variability  between  patients  is
another major limiting factor in the search for
unique omic biomarkers. As a consequence, it
has been suggested to use complex bioinfor-
matic analyses to effectively mine heteroge-
neous quantitative data sets and extract their
qualitative  contents;1 a  consensus,  however,
has not yet been reached on how to deal with
omic data in the attempt to identify suitable
pathological biomarker(s).
The present role of histochem-
istry in clinical pathology
It is since the 1950’s that histochemistry has
been recognized as the discipline linking mor-
phology  (microanatomy  and  histology)  and
biochemistry,  and  has  provided  pathologists
with a versatile armamentarium of methods
and  procedures  enabling  the  recognition  in
situ of significant pathological markers.2,3
The advantage provided by the histochemi-
cal approach is the possibility to detect in situ,
by microscopy techniques, changes in cell phe-
notype taking place even in limited portions of
a  pathological  tissue:  thus  quantitative
changes either in the percentage of cells posi-
tive for a given marker or in the intensity of
the  final  reaction  products  within  the  cells
allow  reliable  diagnostic  conclusion  through
the comparison with the normal tissue, and
well  experienced  pathologists  often  improve
differential diagnosis by selecting a panel of
appropriate histochemical markers. 
On 12-15 October 2011, the 53rd Symposium
of  the  Society  for  Histochemistry  has  been
held in Munich (Germany) with the significant
subtitle  Current  role  of  Histochemistry  in
Preclinical and Clinical Research (http://www
.helmholtz-muenchen.de/histochem-
istry2011/home/index.html).  Also  during  the
34th National Congress of the Italian Society of
Histochemistry,4 more  than  one  third  of  the
scientific contributions concerned the applica-
tion of histochemical techniques to pathologi-
cal models, in humans and other Vertebrates.
This  interest  for  the  application  of  histo-
chemistry  in  the  pathological  field  is  con-
firmed in the international literature: during
the last two years, out of the about 25,000 arti-
cles dealing with the application of histochem-
ical  techniques  published  in  peer-reviewed
journals, more than 50% concerned pathologi-
cal  (mostly  tumour)  subjects  (source:
http://www.ncbi.nlm.nih.gov/pubmed/). 
Consistently,  the  percentage  of  published
articles on pathological topics ranged between
25% and 40%, also in the most traditional jour-
nals on histochemistry, i.e. Histochemistry and
Cell  Biology (http://www.springer.com/medi-
cine/anatomie/journal/418),  the  Journal  of
Histochemistry  and  Cytochemistry (http://jhc.
sagepub.com/), and the European Journal of
Histochemistry (www.ejh.it).
A  review  of  the  contents  of  the  articles
appeared in this latter journal showed that the
majority of them were devoted to tumours.5-24
As expected, immunohistochemistry has been
mostly applied, and the differential expression
of proteins in diseased vs normal tissues has
often been investigated by a multiparametric
approach.7,11,12,14,15,22 A  few  papers  were
focussed  on  the  unusual  expression  of  pro-
teins  demonstrating  possible  heterogeneity
within tumours classified in a single type,6,17
while proliferation, differentiation and apop-
totic markers have been used to elucidate dif-
ferences in the progression of malignancy and
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in the metastatic potential of tumour cells in
vivo and in vitro.6,8,9,14,16,19-21,23,24
Muscle  wasting,  due  to  physiological  sar-
copenia or dystrophy, has been widely consid-
ered:25-30 the simultaneous application of histo-
chemical  techniques  at  light  and  electron
microscopy allowed to relate the changes in
cellular phenotype with altered gene expres-
sion. Changes in the structural and functional
features of the cell nucleus of myocytes and
satellite cells proved to be especially suitable to
detect alterations not only in the organization
of muscle fibres, but also in the regeneration
potential of skeletal muscle under pathological
conditions and aging.25-28 Skeletal muscle has
also been the subject of three interesting tech-
nical  reports;30-32 and  other  notes  on  tech-
niques  have been published concerning the
preparation  of  pathological  samples  to  be
observed  in  bright  field  or  fluorescence
microscopy.33-36
Histological, histochemical and morphomet-
rical techniques have been used to investigate
the effects of intoxication, infection or vaccine
administration on several organs and tissues
from different Vertebrate species, from fish to
mammals:37-43 here too, the potential of light
and  electron  microscopy  and  histochemistry
has been exploited to identify minute changes
in the structural organization and function of
cells which heterogeneously take place in dif-
ferent tissues.
A growing interest is apparent for mineral-
ized  tissues,  with  special  attention  to  joint
alterations  during  development  and  under
pathological  conditions:44-49in particular, artic-
ular  disks  have  been  the  subject  of  several
papers, as the changes in their composition
and  organization  are  indicative  features  to
understand pathological processes of internal
derangement.45-49
In  the  wide  variety  of  pathological  condi-
tions that have been considered in the pub-
lished articles, histochemical techniques have
been used not only to detect specific patholog-
ical markers,50,51 but also to evaluate the effect
of therapies52and to investigate the role of spe-
cific  signalling  molecules  in  the  onset  of
pathological phenotypes.53
Oxidative stress is known as a powerful fac-
tor inducing pathological processes in cells by
modifying their redox state: alterations in some
enzyme activities  have been investigated with
special attention to those occurring as a conse-
quence of hypoxia-reoxygenation.54-57 The evi-
dence that hypoxia and aging in the myocardial
tissue  are  controlled  by  p53  and  telomerase
activity57 confirms that molecular events modi-
fying nuclear structure and function often play a
pivotal role in pathogenesis; this is apparently
confirmed by several articles in which nuclear
histochemistry has been profitably used to elu-
cidate basic mechanisms leading to the patho-
logical cell phenotype.23-27,58-60
Finally,  a  new  frontier  of  histochemistry
seems to open in the field of tissue engineer-
ing,61,62 transplantation,63 and  adipocyte-
derived tissue reconstruction.64,65
Conclusions
The  application  of  refined  techniques  for
investigating  gene  expression  in  situ has
greatly  increased  the  diagnostic/prognostic
potential of histochemistry, while the progress
in  light  microscopy  technology  and  in  the
methods  for  imaging  molecules  in  vivo has
provided a valuable tools for elucidating the
molecular events and the basic mechanisms
leading to a pathological condition.
In particular, nowadays two techniques are
being  utilized  on  pathological  material,  and
they start from opposite directions: the already
established super-resolution techniques such
as  STED  (Stimulated  Emission  Depletion)
microscopy66 are now being tested on cells and
subcellular  structures,  for  purely  diagnostic
purposes, while MALDI (Matrix Assisted Laser
Desorption/Ionization) analysis67 only needs to
approach a sufficiently high resolution to be
profitably  used  at  the  cellular  level.  Consi  -
stently,  in  his  closing  statement  to  the  53rd
Symposium of the Society for Histo  chemistry,
the  President  of  the  Society,  Prof.  Marco
Biggiogera  underlined  that  MALDI  analyses
and  imaging  promise  to  be  extraordinarily
analytical techniques and a new powerful tool
for pathologists.
It might therefore be expected that, even in
the future, histochemistry will keep a leading
position in clinical pathology, and the histo-
chemical journals will continue to be a widely
attended forum for both clinicians and basic
scientists in the biomedical field.
References
1. Abu-Asab MS, Chaouchi M, Alesci S, Galli
S,  Laassri  M,  Cheema  AK,  et  al.
Biomarkers in the age of omics: time for a
systems  biology  approach.  OMICS
2011;15:105-12.
2. Vollmer  E,  Goldman  T.  Pathology  at  the
edge  of  interdisciplinarity:  a  histocrical
epitome.  Rom  J  Morphol  Embryol
52(Suppl.1):2123-30.
3. Pellicciari C. Histochemistry through the
years, browsing a long-established journal:
novelties  in  traditional  subjects.  Eur  J
Histochem. 2010;54:e51.
4. Proceedings of the 33rd National Congress
of  the  Italian  Society  of  Histochemistry,
June  8-10,  2009,  Rome,  Italy.  Eur  J
Histochem 2009;53(Suppl.1):1-56.
5. Kalnina Z, Silina K, Bruvere R, Gabruseva
N, Stengrevics A, Barnikol-Watanabe S, et
al. Molecular characterisation and expres-
sion  analysis  of  SEREX-defined  antigen
NUCB2 in gastric epithelium, gastritis and
gastric cancer. Eur J Histochem 2009;53:7-
18.
6. Pilloni L, Bianco P, Manieli C, Senes G,
Coni P, Atzori L, et al. Immunoreactivity for
alpha-smooth muscle actin characterizes a
potentially  aggressive  subgroup  of  little
basal  cell  carcinomas.  Eur  J  Histochem
2009;53:113-6.
7. Ruggeri  RM,  Ferraù  F,  Campennì  A,
Simone  A,  Barresi  V,  Giuffrè  G,  et  al.
Immunohistochemical  localization  and
functional  characterization  of  somato-
statin receptor subtypes in a corticotropin
releasing  hormone-secreting  adrenal
phaeochromocytoma: review of the litera-
ture and report of a case. Eur J Histochem
2009;53:1-6.
8. Gonelli A, Milani D, Rimondi E, Voltan R,
Grill  V,  Celeghini  C.  Activation  of  PKC-
epsilon counteracts maturation and apop-
tosis of HL-60 myeloid leukemic cells in
response to TNF family members. Eur J
Histochem 2009;53:177-82.
9. Cvejic D, Selemetjev S, Savin S, Paunovic
I, Tatic S. Changes in the balance between
proliferation and apoptosis during the pro-
gression  of  malignancy  in  thyroid
tumours. Eur J Histochem 2009;53:65-71. 
10. Fanni D, Nemolato S, Ganga R, Senes G,
Gerosa C, Van Eyken P, et al. Cytokeratin
20-positive hepatocellular carcinoma. Eur
J Histochem 2009;53:269-73.
11. Pilloni L, Manieli C, Senes G, Ribuffo D,
Faa  G.  Merkel  cell  carcinoma  with  an
unusual  immunohistochemical  profile.
Eur J Histochem 2009;53:275-8.
12. Artico M, Bronzetti E, Alicino V, Ionta B,
Bosco S, Grande C, et al. Human gallblad-
der  carcinoma:  Role  of  neurotrophins,
MIB-1, CD34 and CA15-3. Eur J Histochem
2010;54:e10.
13. Nemolato S, Cabras T, Fanari MU, Cau F,
Fraschini M, Manconi B, et al. Thymosin
beta 4 expression in normal skin, colon
mucosa  and  in  tumor  infiltrating  mast
cells. Eur J Histochem 2010;54:e3.
14. Nowak  D,  Mazur  AJ,  Popow-Woźniak  A,
Radwańska  A,  Mannherz  HG,  Malicka-
Błaszkiewicz  M.  Subcellular  distribution
and  expression  of  cofilin  and  ezrin  in
human  colon  adenocarcinoma  cell  lines
with different metastatic potential. Eur J
Histochem 2010;54:e14.
15. Ruggeri  RM,  Vitarelli  E,  Barresi  G,
Trimarchi F, Benvenga S, Trovato M. The
tyrosine kinase receptor c-met, its cognate
Views and Comments[European Journal of Histochemistry 2011; 55:e42] [page 237]
ligand HGF and the tyrosine kinase recep-
tor  trasducers  STAT3,  PI3K  and  RHO  in
thyroid  nodules  associated  with
Hashimoto's thyroiditis: an immunohisto-
chemical  characterization.  Eur  J  Histo  -
chem 2010;54:e24.
16. Artico M, Bronzetti E, Ionta B, Bruno M,
Greco  A,  Ruoppolo  G,  et  al.  Reinke's
edema: investigations on the role of MIB-1
and  hepatocyte  growth  factor.  Eur  J
Histochem 2010;54:e30.
17. Perrone G, Morini S, Santini D, Rabitti C,
Vincenzi B, Alloni R, et al. Human equili-
brative nucleoside transporter 1 and carci-
noma of the ampulla of Vater: expression
differences  in  tumour  histotypes.  Eur  J
Histochem 2010;54:e38.
18. Salemi  M,  Calogero  AE,  Zaccarello  G,
Castiglione R, Cosentino A, Campagna C,
et al. Expression of SPANX proteins in nor-
mal prostatic tissue and in prostate cancer.
Eur J Histochem 2010;54:e41.
19. Bujas T, Marusic Z, Peric Balja M, Mijic A,
Kruslin B, Tomas D. MAGE-A3/4 and NY-
ESO-1 antigens expression in metastatic
esophageal squamous cell carcinoma. Eur
J Histochem 2011;55:e7.    
20. Protrka  Z,  Arsenijevic  S,  Dimitrijevic  A,
Mitrovic S, Stankovic V, Milosavljevic M, et
al. Co-overexpression of bcl-2 and c-myc in
uterine cervix carcinomas and premalig-
nant lesions. Eur J Histochem 2011;55:e8.
21. Shen Z, Ren Y, Ye D, Guo J, Kang C, Ding
H. Significance and relationship between
DJ-1 gene and survivin gene expression in
laryngeal  carcinoma.  Eur  J  Histochem
2011;55:e9.    
22. Pilloni L, Bianco P, Difelice E, Cabras S,
Castellanos ME, Atzori L, et al. The useful-
ness of c-Kit in the immunohistochemical
assessment of melanocytic lesions. Eur J
Histochem 2011;55:e20.
23. Tsirakis  G,  Pappa  CA,  Kaparou  M,
Katsomitrou V, Hatzivasili A, Alegakis T, et
al. Assessment of proliferating cell nuclear
antigen  and  its  relationship  with  proin-
flammatory  cytokines  and  parameters  of
disease  activity  in  multiple  myeloma
patients. Eur J Histochem 2011;55:e21.
24. Piras F, Ionta MT, Lai S, Perra MT, Atzori F,
Minerba L, et al. Nestin expression associ-
ates with poor prognosis and triple nega-
tive  phenotype  in  locally  advanced  (T4)
breast  cancer.  Eur  J  Histochem  2011;
55:e39.
25. Malatesta M, Meola G. Structural and func-
tional  alterations  of  the  cell  nucleus  in
skeletal muscle wasting: the evidence in
situ. Eur J Histochem 2010;54:e44.
26. Perdoni  F,  Malatesta  M,  Cardani  R,
Giagnacovo M, Mancinelli E, Meola G, et
al.  RNA/MBNL1-containing  foci  in
myoblast nuclei from patients affected by
myotonic dystrophy type 2: an immunocy-
tochemical study. Eur J Histochem 2009;
53:151-8.
27. Malatesta  M,  Perdoni  F,  Muller  S,
Zancanaro C, Pellicciari C. Nuclei of aged
myofibres  undergo  structural  and  func-
tional changes suggesting impairment in
RNA processing. Eur J Histochem 2009;53:
97-106.
28. Malatesta  M,  Giagnacovo  M,  Renna  LV,
Cardani R, Meola G, Pellicciari C. Cultured
myoblasts  from  patients  affected  by
myotonic dystrophy type 2 exhibit senes-
cence-related features: ultrastructural evi-
dence. Eur J Histochem 2011;55:e26.
29. Casadei  L,  Vallorani  L,  Gioacchini  AM,
Guescini M, Burattini S, D'Emilio A, et al.
Proteomics-based investigation in C2C12
myoblast differentiation. Eur J Histochem
2009;53:261-8.
30. Cardani  R,  Mancinelli  E,  Giagnacovo  M,
Sansone  V,  Meola  G.  Ribonuclear  inclu-
sions as biomarker of myotonic dystrophy
type  2,  even  in  improperly  frozen  or
defrozen skeletal muscle biopsies. Eur J
Histochem 2009;53:107-11.
31. Karen P, Števanec M, Smerdu V, Cvetko E,
Kubínová L, Eržen I. Software for muscle
fibre type classification and analysis. Eur J
Histochem 2009;53:87-95.
32. Giagnacovo  M,  Cardani  R,  Meola  G,
Pellicciari  C,  Malatesta  M.  Routinely
frozen biopsies of human skeletal muscle
are  suitable  for  morphological  and
immunocytochemical  analyses  at  trans-
mission  electron  microscopy.  Eur  J
Histochem 2010;54:e31.
33. Xue  J,  Chen  H,  Diao  L,  Chen  X,  Xia  D.
Expression of caveolin-1 in tongue squa-
mous cell carcinoma by quantum dots. Eur
J Histochem 2010;54:e20.
34. Petr  T,  Smíd  V,  Smídová  J,  Hůlková  H,
Jirkovská  M,  Elleder  M,  et  al.
Histochemical detection of GM1 ganglio-
side  using  cholera  toxin-B  subunit.
Evaluation of critical factors optimal for in
situ  detection  with  special  emphasis  to
acetone  pre-extraction.  Eur  J  Histochem
2010;54:e23.
35. Relucenti  M,  Heyn  R,  Petruzziello  L,
Pugliese  G,  Taurino  M,  Familiari  G.
Detecting  microcalcifications  in  athero-
sclerotic  plaques  by  a  simple  trichromic
staining  method  for  epoxy  embedded
carotid  endarterectomies.  Eur  J  Histo  -
chem 2010;54:e33.
36. Galvão MJ, Santos A, Ribeiro MD, Ferreira
A, Nolasco F. Optimization of the tartrate-
resistant  acid  phosphatase  detection  by
histochemical  method.  Eur  J  Histochem
2011;55:e1. 
37. Battistelli S, Citterio B, Baldelli B, Parlani
C, Malatesta M. Histochemical and mor-
pho-metrical  study  of  mouse  intestine
epithelium after a long term diet contain-
ing  genetically  modified  soybean.  Eur  J
Histochem. 2010;54:e36.
38. Magi GE, Lopez-Romalde S, Magariños B,
Lamas  J,  Toranzo  AE,  Romalde  JL.
Experimental Pseudomonas anguillisepti-
ca infection in turbot Psetta maxima (L.):
a  histopathological  and  immunohisto-
chemical  study.  Eur  J  Histochem  2009;
53:73-9.
39. Kovšca Janjatović A, Lacković G, Bozić F,
Spoljarić D, Popović M, Valpotić H, et al.
Histomorphometric  characteristics  of
immune  cells  in  small  intestine  of  pigs
perorally immunized with vaccine candi-
date  F18ac+  nonenterotoxigenic  E.  coli
strain. Eur J Histochem 2009;53:189-98.
40. Kovšca Janjatović A, Lacković G, Bozić F,
Kezić D,  Popović M,  Valpotić H,  et  al.
Histomorphometric evaluation of intestin-
al  cellular  immune  responses  in  pigs
immunized  with  live  oral  F4ac+  non-
enterotoxigenic  E.  coli  vaccine  against
postweaning  colibacillosis.  Eur  J  Histo  -
chem 2010;54:e4.
41. Dorko F, Danko J, Flešárová S, Boroš E,
Sobeková A. Effect of pesticide bendiocar-
bamate  on  distribution  of  acetylcholine-
and butyrylcholine-positive nerves in rab-
bit’s thymus. Eur J Histochem 2011;55:e37.    
42. Costa CA, De Brito KN, Gomes MA, Caliari
MV.  Histopathological  and  immunohisto-
chemical  study  of  the  hepatic  lesions
experimentally induced by Entamoeba dis-
par. Eur J Histochem 2010;54:e39.
43. Ferrandino  I,  Favorito  R,  Grimaldi  MC.
Cadmium induces changes on ACTH and
PRL cells in Podarcis sicula lizard pituitary
gland. Eur J Histochem 2010;54:e45.
44. Ruggeri A, Orsini G, Mazzoni A, Nato F,
Papa  V,  Piccirilli  M,  et  al.  Immunohi  -
stochemical and biochemical assay of ver-
sican in human sound predentine/dentine
matrix. Eur J Histochem 2009;53:125-33.
45. Kiga N, Tojyo I, Matsumoto T, Hiraishi Y,
Shinohara Y, Makino S, et al. Expression
of  lumican  and  fibromodulin  following
interleukin-1 beta stimulation of disc cells
of  the  human  temporomandibular  joint.
Eur J Histochem 2011;55:e11.
46. Kiga N, Tojyo I, Matsumoto T, Hiraishi Y,
Shinohara Y, Fujita S. Expression of lumi-
can in the articular disc of the human tem-
poromandibular  joint.  Eur  J  Histochem
2010;54:e34.
47. Loreto  C,  Almeida  LE,  Migliore  MR,
Caltabiano M, Leonardi R. TRAIL, DR5 and
caspase 3-dependent apoptosis in vessels
of  diseased  human  temporomandibular
joint disc. An immunohistochemical study.
Eur J Histochem 2010;54:e40.
48. Matsumoto T, Inayama M, Tojyo I, Kiga N,
Views and Comments[page 238] [European Journal of Histochemistry 2011; 55:e42]
Views and Comments
Fujita  S.  Expression  of  hyaluronan  syn-
thase  3  in  deformed  human  temporo-
mandibular joint discs: in vivo and in vitro
studies. Eur J Histochem 2010;54:e50.
49. de  Moraes  LOC,  Lodi  FR,  Gomes  TS,
Oshima CTF, Marques SR, Lancellotti CLP,
et al. Immunohistochemical expression of
types I and III collagen antibodies in the
temporomandibular  joint  disc  of  human
foetuses. Eur J Histochem 2011;55:e24.
50. Song R, Xu W, Chen Y, Li Z, Zeng Y, Fu Y.
The  expression  of  Sirtuins  1  and  4  in
peripheral blood leukocytes from patients
with  type  2  diabetes.  Eur  J  Histochem
2011;55:e10.
51. Sharma P, Kar R, Dutta S, Pati HP, Saxena
R.  Niemann-Pick  disease,  type  B  with
TRAP-positive storage cells and secondary
sea  blue  histiocytosis.  Eur  J  Histochem
2009;53:183-6.
52. Tomasello G, Sciumé C, Rappa F, Rodolico
V,  Zerilli  M,  Martorana  A,  et  al.  Hsp10,
Hsp70, and Hsp90 immunohistochemical
levels  change  in  ulcerative  colitis  after
therapy. Eur J Histochem 2011;55:e38.
53. Markelic M, Velickovic K, Golic I, Otasevic
V, Stancic A, Jankovic A, et al. Endothelial
cell apoptosis in brown adipose tissue of
rats  induced  by  hyperinsulinaemia:  the
possible role of TNF-ʱ. Eur J Histochem
2011;55:e34.
54. Lepore  G,  Gadau  S,  Mura  A,  Zedda  M,
Farina V. Aromatase immunoreactivity in
fetal ovine neuronal cell cultures exposed
to  oxidative  injury.  Eur  J  Histochem
2009;53:233-8.
55. Rus A, Del Moral ML, Molina F, Peinado
MA. Upregulation of cardiac NO/NOS sys-
tem  during  short-term  hypoxia  and  the
subsequent  reoxygenation  period.  Eur  J
Histochem 2011;55:e17.
56. Bolekova A, Spakovska T, Kluchova D, Toth
S, Vesela J. NADPH-diaphorase expression
in  the  rat  jejunum  after  intestinal
ischemia/reperfusion.  Eur  J  Histochem
2011;55:e23.    
57. Cataldi A, Zara S, Rapino M, Zingariello M,
di Giacomo V, Antonucci A. p53 and telom-
erase  control  rat  myocardial  tissue
response  to  hypoxia  and  ageing.  Eur  J
Histochem 2009;53:209-16.
58. Dominici S, Fiori V, Magnani M, Schena E,
Capanni  C,  Camozzi  D,  et  al.  Different
prelamin  A  forms  accumulate  in  human
fibroblasts: a study in experimental mod-
els  and  progeria.  Eur  J  Histochem
2009;53:43-52.
59. Cortés-Gutiérrez EI, Dávila-Rodríguez MI,
Fernández  JL,  López-Fernández  C,
Gosálvez  J.  Koilocytes  are  enriched  for
alkaline-labile  sites.  Eur  J  Histochem
2010;54:e32.
60. Cenni  V,  Capanni  C,  Columbaro  M,
Ortolani M, D'Apice MR, Novelli G, et al.
Autophagic  degradation  of  farnesylated
prelamin A as a therapeutic approach to
lamin-linked  progeria.  Eur  J  Histochem
2011;55:e36.
61. Corallini F, Gonelli A, D’Aurizio F, Di Iasio
MG,  Vaccarezza  M.  Mesenchymal  stem
cells-derived vascular smooth muscle cells
release  abundant  levels  of  osteoprote-
gerin. Eur J Histochem 2009;53:19-24.
62. Musumeci  G,  Loreto  C,  Carnazza  ML,
Coppolino  F,  Cardile  V,  Leonardi  R.
Lubricin  is  expressed  in  chondrocytes
derived  from  osteoarthritic  cartilage
encapsulated  in  poly(ethylene  glycol)
diacrylate scaffold. Eur J Histochem 2011;
55:e31. 
63. Boncompagni  E,  Gini  E,  Ferrigno  A,
Milanesi  G,  Gringeri  E,  Barni  S,  et  al.
Decreased apoptosis in fatty livers submit-
ted  to  subnormothermic  machine-perfu-
sion  respect  to  cold  storage.  Eur  J
Histochem 2011;55:e40.
64. Sbarbati A, Accorsi D, Benati D, Marchetti
L, Orsini G, Rigotti G, et al. Subcutaneous
adipose  tissue  classification.  Eur  J
Histochem 2010;54:e48.
65. Panettiere  P,  Accorsi  D,  Marchetti  L,
Minicozzi AM, Orsini G, Bernardi P, et al.
The trochanteric fat pad. Eur J Histochem
2011;55:e16.
66. Leung BO, Chou KC. Review of super-res-
olution fluorescence microscopy for biolo-
gy. Appl Spectrosc 2011;65:967-80.
67. Balluff B, Schoene C, Hoefler H, Walch A.
MALDI  imaging  mass  spectrometry  for
direct  tissue  analysis:  technological
advancements  and  recent  applications.
Histochem Cell Biol 2011;136:227-44.